Personalized Dosing Plan GLP-1 medications typically start at a low dose, gradually increasing to minimize side effects and maximize tolerability
Retatrutide comprises 39 amino acids and is based on the structure of the incretin hormone GIP, but it is also modified to activate GLP-1 and GCG receptors, with a bias towards GIP receptor activation [15]
Your provider will demonstrate proper subcutaneous injection technique, which involves injecting into the fatty tissue just beneath the skin in the abdomen, thigh, or upper arm
Choose 50mg if the study requires more volume, longer observation, or repeated research phases
Frank, M
Dolma S, Lessnick SL, Hahn WC, Stockwell BR